|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.48 SEK | -1.38% |
|
-0.81% | +0.53% |
| 02/04 | EFN highlights twelve stock picks for Q2, announces three portfolio rotations | FW |
| 13/03 | Vimian appoints Lotta Lundaas as Head of MedTech | FW |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 5 | |||||||
| 17 | |||||||
| 14 | |||||||
| 2 | |||||||
| 9 | |||||||
| 2 | |||||||
| 5 | |||||||
| 4 | |||||||
| 2 | |||||||
| 5 | |||||||
| 3 | |||||||
| - | - | ||||||
| - | - | ||||||
| 2 | |||||||
| 2 | |||||||
| 2 | |||||||
| Average | 5 | |||||||
| Weighted average by Cap. | 13 |
- Stock Market
- Equities
- VIMIAN Stock
- Sector Vimian Group AB
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition